Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mesoblast Ltd (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Mesoblast Limited (ASX- MSB; Nasdaq- MESO)

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Th...

26 Aug 2016 Acquisdata 17 $15.00

Mesoblast Limited - Mesoblast Reports Financial Results and Operational Highlights for the Three Months and for the Year Ended 30 June 2016

25 Aug 2016 irasia.com 9 $104.00

MESOBLAST LTD (MESO=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

20 Aug 2016 Pechala's Reports 2 $25.00

Mesoblast Limited (MSB) - Financial Analysis Review

Mesoblast Limited (MSB) - Financial Analysis Review Summary Mesoblast Limited (Mesoblast) is a regenerative medicine company ...

17 Aug 2016 GlobalData 50 $300.00

Mesoblast Limited - Mesoblast Strengthens Key United States Patent Portfolio for the Treatment of Rheumatic Diseases

17 Aug 2016 irasia.com 3 $35.00

ValuEngine Rating and Forecast Report for MESO

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

14 Aug 2016 ValuEngine, Inc. 11 $25.00

The ASX: Investing in an Emerging Biotech Frontier

Concerned about investing in the life sciences in the United States, where markets have slumped in 2016 and the presidential ...

10 Aug 2016 Streetwise Reports 4 $23.00